Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 2Phase 3 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 2Plasma cell 1

Conditions

Leukemia, Myeloid, Acute 25Leukemia 13Neuroblastoma 12Myelodysplastic Syndromes 12Multiple Myeloma 12Recurrence 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma 8Sarcoma 7Medulloblastoma 7Astrocytoma 7Lymphoma, Non-Hodgkin 6Wilms Tumor 5Osteosarcoma 5Central Nervous System Neoplasms 5Brain Neoplasms 5Sarcoma, Ewing 4Rhabdoid Tumor 4Retinoblastoma 4Optic Nerve Glioma 4Neoplasms 4Myeloproliferative Disorders 4Lymphoma, Mantle-Cell 4Lymphoma, Follicular 4Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia, Biphenotypic, Acute 4Hodgkin Disease 4Hematologic Neoplasms 4Burkitt Lymphoma 4Testicular Neoplasms 3

Interventions

Cyclophosphamide 11ruxolitinib 10fludarabine phosphate 9Tacrolimus 7Filgrastim 7fludarabine 6Decitabine 6Whole-Body Irradiation 5Peripheral Blood Stem Cell Transplantation 5Mycophenolic Acid 5Busulfan 5navitoclax 4Sirolimus 4Etoposide 4Azacitidine 4Specimen Handling 3Methylprednisolone 3Methotrexate 3Melphalan 3Cyclosporine 3Antilymphocyte Serum 3venetoclax 2thymoglobulin 2durvalumab 2Vorinostat 2Thiotepa 2Sunitinib 2Stem Cell Transplantation 2Radiotherapy 2Prednisone 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Primary Myelofibrosis × Granulocyte Colony-Stimulating Factor × Clear all
NCT03018223 2021-09-16

Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Completed
32 enrolled 12 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myelomonocytic, Chronic, Primary Myelofibrosis

NCT02167958 2019-10-15

Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source

University of Pittsburgh

Phase 1 Completed
28 enrolled
LymphoidMyeloidOther hematologic neoplasm

Leukemia, Lymphoma, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡